Compare PKST & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKST | EMBC |
|---|---|---|
| Founded | 2008 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 574.7M | 602.3M |
| IPO Year | 2014 | 2021 |
| Metric | PKST | EMBC |
|---|---|---|
| Price | $20.86 | $10.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $21.00 | $18.50 |
| AVG Volume (30 Days) | ★ 1.1M | 894.3K |
| Earning Date | 05-22-2026 | 05-09-2026 |
| Dividend Yield | 1.92% | ★ 5.59% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.74 |
| Revenue | ★ $105,981,000.00 | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.35 | $9.20 |
| 52 Week High | $20.97 | $15.55 |
| Indicator | PKST | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 87.96 | 43.78 |
| Support Level | $20.70 | $9.93 |
| Resistance Level | $20.97 | $10.70 |
| Average True Range (ATR) | 0.12 | 0.68 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 45.00 | 17.40 |
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.